This study not only identified several metabolites of diagnostic and prognostic value but also provided an accurate metabolite‐based predictive model for ESCC tissue classification and identified three upregulated amino acid transporters [63, 64, 65, 66] as potential therapeutic targets for ESCC, especially SLC1A5. This evidence concerns the gene SLC38A7 and esophageal squamous cell carcinoma.